Progesterone treatment shows benefit in a pediatric model of moderate to severe bilateral brain injury.
OBJECTIVE
Controlled cortical impact (CCI) models in adult and aged Sprague-Dawley (SD) rats have been used extensively to study medial prefrontal cortex (mPFC) injury and the effects of post-injury progesterone treatment, but the hormone's effects after traumatic brain injury (TBI) in juvenile animals have not been determined. In the present proof-of-concept study we investigated whether progesterone had neuroprotective effects in a pediatric model of moderate to severe bilateral brain injury.


METHODS
Twenty-eight-day old (PND 28) male Sprague Dawley rats received sham (n = 24) or CCI (n = 47) injury and were given progesterone (4, 8, or 16 mg/kg per 100 g body weight) or vehicle injections on post-injury days (PID) 1-7, subjected to behavioral testing from PID 9-27, and analyzed for lesion size at PID 28.


RESULTS
The 8 and 16 mg/kg doses of progesterone were observed to be most beneficial in reducing the effect of CCI on lesion size and behavior in PND 28 male SD rats.


CONCLUSIONS
Our findings suggest that a midline CCI injury to the frontal cortex will reliably produce a moderate TBI comparable to what is seen in the adult male rat and that progesterone can ameliorate the injury-induced deficits.
Department of Emergency Medicine, Emory University, Atlanta, Georgia, United States of America.
Rastafa I
RI
Geddes
Department of Emergency Medicine, Emory University, Atlanta, Georgia, United States of America.
Eric A
EA
Sribnick
Department of Emergency Medicine, Emory University, Atlanta, Georgia, United States of America.
Iqbal
I
Sayeed
Department of Emergency Medicine, Emory University, Atlanta, Georgia, United States of America.
Donald G
DG
Stein
D000367:Age Factors; D000818:Animals; D001522:Behavior, Animal / Q000187:drug effects; D001930:Brain Injuries / Q000188:drug therapy* / Q000473:pathology; D008297:Male; D011374:Progesterone / Q000008:administration & dosage / Q000627:therapeutic use*; D011372:Progestins / Q000008:administration & dosage / Q000627:therapeutic use*; D051381:Rats; D017207:Rats, Sprague-Dawley
D011372:Progestins; D011374:Progesterone